• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫浆液性乳头状癌胸膜复发姑息化疗的良好反应

Excellent Response to Palliative Chemotherapy for Pleural Recurrence of Uterine Papillary Serous Carcinoma.

作者信息

Singh Shantanu, Mack David, Dookhan Dianne, Jyotimallika Juthika

机构信息

Duke LPMP Medical Center, North Carolina, USA.

出版信息

World J Oncol. 2013 Oct;4(4-5):210-213. doi: 10.4021/wjon704w. Epub 2013 Sep 27.

DOI:10.4021/wjon704w
PMID:29147358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5649930/
Abstract

Uterine papillary serous carcinoma (UPSC) is an aggressive variant of endometrial cancer. Though the majority of women with UPSC have high risk of recurrence, recurrence limited only to the pleural space has not been previously reported. It is also unusual for it to occur as late as 10 years after the initial treatment as it is usually very aggressive. There is scant information in literature on response to treatment in these patients. A 65-year-old African-American woman was treated for FIGO stage IIA UPSC with total abdominal hysterectomy, bilateral salpingo-oophorectomy, and pelvic lymphadenectomy with P catheter placement, followed by adjuvant external beam radiation. She relapsed 10 years later with right pleural effusion and pleural based nodules. Fluid cytology was consistent with UPSC. She was treated with 6 cycles of carboplatin and paclitaxel with excellent clinical and biochemical response. She continues to remain disease free 5 years later. To our knowledge, this is the first reported case of UPSC recurrence limited to pleura, and this is also the first reported case of UPSC recurrence without evidence of disease 5 years after palliative chemotherapy.

摘要

子宫浆液性乳头状癌(UPSC)是子宫内膜癌的一种侵袭性亚型。尽管大多数UPSC患者有较高的复发风险,但此前尚未有仅局限于胸腔的复发报道。它在初始治疗10年后才发生也不常见,因为它通常具有很强的侵袭性。关于这些患者对治疗反应的文献资料很少。一名65岁的非裔美国女性因FIGO IIA期UPSC接受了全腹子宫切除术、双侧输卵管卵巢切除术和盆腔淋巴结清扫术并放置P导管,随后进行辅助外照射放疗。她在10年后复发,出现右侧胸腔积液和胸膜下结节。胸水细胞学检查结果与UPSC相符。她接受了6个周期的卡铂和紫杉醇治疗,临床和生化反应良好。5年后她仍无疾病复发。据我们所知,这是首例报道的UPSC复发局限于胸膜的病例,也是首例报道的在姑息化疗5年后无疾病证据的UPSC复发病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/5649930/65dc49187a2e/wjon-04-210-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/5649930/8b1e29189c13/wjon-04-210-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/5649930/e5cd25c9780a/wjon-04-210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/5649930/3d7faba95cd7/wjon-04-210-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/5649930/0acebdc011ca/wjon-04-210-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/5649930/65dc49187a2e/wjon-04-210-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/5649930/8b1e29189c13/wjon-04-210-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/5649930/e5cd25c9780a/wjon-04-210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/5649930/3d7faba95cd7/wjon-04-210-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/5649930/0acebdc011ca/wjon-04-210-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f77/5649930/65dc49187a2e/wjon-04-210-g005.jpg

相似文献

1
Excellent Response to Palliative Chemotherapy for Pleural Recurrence of Uterine Papillary Serous Carcinoma.子宫浆液性乳头状癌胸膜复发姑息化疗的良好反应
World J Oncol. 2013 Oct;4(4-5):210-213. doi: 10.4021/wjon704w. Epub 2013 Sep 27.
2
Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.高剂量率阴道顶端放射治疗(192铱)联合化疗对Ⅰ期子宫浆液性乳头状癌的有效治疗
Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):77-84. doi: 10.1016/s0360-3016(97)00581-6.
3
Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.子宫浆液性乳头状癌多模式治疗后的失败模式
Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):208-16. doi: 10.1016/s0360-3016(03)00531-5.
4
Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.Ⅰ-Ⅱ期乳头状浆液性子宫内膜癌辅助卡铂/紫杉醇化疗和阴道内放疗的 5 年结果。
Gynecol Oncol. 2012 Nov;127(2):321-5. doi: 10.1016/j.ygyno.2012.07.112. Epub 2012 Jul 28.
5
Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.接受辅助铂类化疗的手术I期子宫浆液性乳头状癌(UPSC)患者生存率提高。
Gynecol Oncol. 2005 Sep;98(3):353-9. doi: 10.1016/j.ygyno.2005.06.012.
6
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy.子宫浆液性乳头状癌:Ⅰ期手术患者接受辅助治疗与未接受辅助治疗的结局比较。
Gynecol Oncol. 2003 Dec;91(3):470-5. doi: 10.1016/j.ygyno.2003.08.027.
7
Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma.子宫浆液性乳头状癌的辅助序贯化疗与放疗
Gynecol Oncol. 2005 Apr;97(1):171-7. doi: 10.1016/j.ygyno.2005.01.001.
8
Abdominal wall metastasis of uterine papillary serous carcinoma in a post-menopausal woman: a case report.一名绝经后女性子宫浆液性乳头状癌的腹壁转移:病例报告
J Menopausal Med. 2014 Apr;20(1):35-8. doi: 10.6118/jmm.2014.20.1.35. Epub 2014 Apr 28.
9
The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).辅助铂类化疗在Ⅰ期子宫浆液性乳头状癌(UPSC)中的疗效。
Gynecol Oncol. 2005 Dec;99(3):557-63. doi: 10.1016/j.ygyno.2005.07.104. Epub 2005 Sep 8.
10
Adrenal Metastasis from Uterine Papillary Serous Carcinoma.子宫浆液性乳头状癌的肾上腺转移
Am J Case Rep. 2016 Apr 27;17:289-94. doi: 10.12659/ajcr.895143.

本文引用的文献

1
Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study.子宫乳头状浆液性癌患者的治疗失败和生存分析:合作任务组(CTF)研究。
Int J Gynecol Cancer. 2012 Oct;22(8):1355-60. doi: 10.1097/IGC.0b013e318267f7a0.
2
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.子宫内膜癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2010 May;21 Suppl 5:v41-5. doi: 10.1093/annonc/mdq245.
3
Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review.
子宫浆液性乳头状癌女性患者的管理:妇科肿瘤学会(SGO)综述
Gynecol Oncol. 2009 Oct;115(1):142-153. doi: 10.1016/j.ygyno.2009.06.011. Epub 2009 Jul 9.
4
Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes.子宫体非子宫内膜样腺癌:特定组织学亚型综述
Cancer Control. 2009 Jan;16(1):46-52. doi: 10.1177/107327480901600107.
5
Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma.术前血清CA-125在子宫浆液性乳头状癌管理中的应用
Gynecol Oncol. 2008 Sep;110(3):293-8. doi: 10.1016/j.ygyno.2008.05.027. Epub 2008 Jul 21.
6
Outcomes in surgical stage I uterine papillary serous carcinoma.手术I期子宫浆液性乳头状癌的预后
Gynecol Oncol. 2007 Jun;105(3):677-82. doi: 10.1016/j.ygyno.2007.01.041. Epub 2007 Mar 13.
7
Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors.术前子宫内膜取样检测高级别子宫内膜肿瘤的准确性。
Am J Obstet Gynecol. 2007 Mar;196(3):243.e1-5. doi: 10.1016/j.ajog.2006.09.035.
8
Endometrial carcinoma with pleural metastasis: A case report.子宫内膜癌伴胸膜转移:一例报告。
Acta Cytol. 2006 Nov-Dec;50(6):697-700. doi: 10.1159/000326045.
9
Thoracic manifestations of common nonpulmonary malignancies of women.女性常见非肺部恶性肿瘤的胸部表现
Clin Chest Med. 2004 Jun;25(2):379-90. doi: 10.1016/j.ccm.2004.01.009.
10
Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.子宫浆液性乳头状癌多模式治疗后的失败模式
Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):208-16. doi: 10.1016/s0360-3016(03)00531-5.